Prevention of neurodevelopmental sequelae of jaundice in the newborn

Developmental Medicine and Child Neurology

Volumn 53, Issue SUPPL.4, 2011, Pages 24-28

  Hansen, Thor W R ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; PHENOBARBITAL;

BILIRUBIN BLOOD LEVEL; BREAST MILK; DISEASE COURSE; DISEASE SEVERITY; ENTERIC FEEDING; EXCHANGE BLOOD TRANSFUSION; HIGH RISK INFANT; HUMAN; IMMUNOTHERAPY; INCIDENCE; INFANT FEEDING; KERNICTERUS; NEUROTOXICITY; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCORING SYSTEM;

BRAIN; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; RISK FACTORS;

EID: 80053164227     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.04059.x     Document Type: Review

References (19)

1. Bhutani VK, Johnson L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol 2009; 29: S61-7.
2. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992-2004). J Perinatol 2009; 29: S25-45.
3. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001; 107: 1075-80.
4. Hansen TWR, Nietsch L, Norman E, et al. Apparent reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr 2009; 98: 1689-94.
5. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000; 89: 1213-7.
6. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650-62.
7. Hansen TWR. Pioneers in the scientific study of neonatal jaundice and kernicterus. Pediatrics 2000; 106: e15.
8. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
9. Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92: F342-6.
10. Johnson L, Brown AK, Bhutani VK. BIND - a clinical score for bilirubin induced neurologic dysfunction. Pediatrics 1999; 104: 746 [Abstract].
11. Arens LJ, Molteno CD, Marshall SR, Robertson WI, Rabkin J. Cerebral palsy in Cape Town: a comparative 12-year retrospective study. S Afr Med J 1978; 53: 319-24.
12. Maisels MJ. Jaundice. In: MacDonald MG, Mullett MD, Seshia MMK, editors. Avery's neonatology. Pathophysiology and management of the newborn. 6th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2005: 768-846.
13. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89: 809-18.
14. Provisional committee on quality improvement subcommittee on hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558-65.
15. Katar S, Akay HO, Taskesen M, Devecioglu C. Clinical and cranial magnetic resonance imaging (MRI) findings of 21 patients with serious hyperbilirubinemia. J Child Neurol 2008; 23: 415-7.
16. Hansen TWR. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997; 86: 843-6.
17. Hansen TWR. Bilirubin entry into and clearance from rat brain during hypercarbia and hyperosmolality. Pediatr Res 1996; 39: 72-6.
18. Huizing KMN, Røislien J, Hansen TWR. Intravenous immunoglobulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. Acta Paediatr 2008; 97: 1362-5.
19. Gourley GR, Kreamer B, Cohnen M, et al. Neonatal jaundice and diet. Arch Pediatr Adolesc Med 1999; 153: 184-8.